BRAND_ANALYSIS#ASTRAZENECAHEALTH & PHARMA#9 OF 26 IN HEALTH & PHARMAINTERESTING
AstraZeneca
· Public · Updated 09 Jul 2026 08:27 UTC
#130 of 1208 overall by tension · #9 of 26 in Health & Pharma
22Interesting
The Silent Giant
Analysis
AstraZeneca inverts the pattern: strong business (B=80) and structural cultural weight (C=58) crushed by -0.20 sentiment, likely tied to vaccine skepticism and pharma distrust. Financial performance cannot outrun reputational gravity.
IN THE NEWS (100 articles this week)
AstraZeneca stock dives 9% after heart drug trial misses target - CNBC
AstraZeneca secures ex-China license for Sino Biopharmaceutical's experimental COPD drug - Reuters
Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership - WSJ